HLA-S and multiple sclerosis: One of the drawbacks of the proposed methodology follows from the fact that in case when the HLA disease association is relatively vague with no predominant HLA disease susceptibility [e.g., multiple sclerosis (27) or type 1 diabetes (28)], a huge cohort of donors featuring various HLAs should be used to detect potential TCR motifs for self-antigens.